Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Minnesota as a location under the Locations section and removed the HHS Vulnerability Disclosure text/link from the footer.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check33 days agoChange DetectedAdded: a note that publications are automatically filled from PubMed and may not be about the study, and a new revision tag (v3.3.2); removed the older PubMed-origin text and the earlier revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a general government funding status notice from the page. The notice previously informed users about potential delays and updates due to funding and operating status of NIH facilities.SummaryDifference0.4%

- Check54 days agoChange DetectedThe new version shows minor UI and formatting updates with no changes to the study's core details (eligibility, outcomes, dosing, or locations).SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.